Literature DB >> 24410552

Trends in generic prescribing and dispensing in Europe.

Steven Simoens1.   

Abstract

Pressure to control pharmaceutical expenditure and price competition among pharmaceutical companies are fuelling the development of generic medicines markets in ambulatory care in Europe. The aim of this special report is to identify, interpret and discuss the main supply and demand trends affecting the European generic medicines market in ambulatory care. On the supply side, generic price-regulated systems and reference pricing systems are spreading across Europe. On the demand side, European countries have attempted to stimulate demand for generic medicines by focusing on physician prescribing, generic substitution by pharmacists and patient copayments. Finally, the development of biosimilars will probably become an important area of growth for the pharmaceutical industry over the next 5 years.

Entities:  

Year:  2008        PMID: 24410552     DOI: 10.1586/17512433.1.4.497

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  12 in total

Review 1.  Impact of European pharmaceutical price regulation on generic price competition: a review.

Authors:  Jaume Puig-Junoy
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs.

Authors:  Brian Godman; Ulrich Schwabe; Gisbert Selke; Björn Wettermark
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia.

Authors:  Zorica Pejčić; Katarina Vučićević; Alfredo García-Arieta; Branislava Miljković
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

Review 4.  Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU.

Authors:  Rena M Conti; William V Padula; Richard A Larson
Journal:  Ann Hematol       Date:  2015-03-27       Impact factor: 3.673

5.  Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway.

Authors:  Helle Håkonsen; Else-Lydia Toverud
Journal:  Eur J Clin Pharmacol       Date:  2010-12-16       Impact factor: 2.953

6.  Policies to enhance prescribing efficiency in europe: findings and future implications.

Authors:  Brian Godman; William Shrank; Morten Andersen; Christian Berg; Iain Bishop; Thomas Burkhardt; Kristina Garuoliene; Harald Herholz; Roberta Joppi; Marija Kalaba; Ott Laius; Julie Lonsdale; Rickard E Malmström; Jaana E Martikainen; Vita Samaluk; Catherine Sermet; Ulrich Schwabe; Inês Teixeira; Lesley Tilson; F Cankat Tulunay; Vera Vlahović-Palčevski; Kamila Wendykowska; Bjorn Wettermark; Corinne Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2011-01-07       Impact factor: 5.810

Review 7.  Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

Authors:  Brian Godman; William Shrank; Bjorn Wettermark; Morten Andersen; Iain Bishop; Thomas Burkhardt; Kristina Garuolienè; Marija Kalaba; Ott Laius; Roberta Joppi; Catherine Sermet; Ulrich Schwabe; Inês Teixeira; F Cankat Tulunay; Kamila Wendykowska; Corinne Zara; Lars L Gustafsson
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-05

8.  Assessment of knowledge and perceptions toward generic medicines among basic science undergraduate medical students at Aruba.

Authors:  P Ravi Shankar; Burton L Herz; Arun K Dubey; Mohamed A Hassali
Journal:  Indian J Pharmacol       Date:  2016-10       Impact factor: 1.200

9.  Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug Approval.

Authors:  Aaron S Kesselheim; Wesley Eddings; Tara Raj; Eric G Campbell; Jessica M Franklin; Kathryn M Ross; Lisa A Fulchino; Jerry Avorn; Joshua J Gagne
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

10.  Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss Cohort.

Authors:  Valérie Piguet; Stéphanie D'Incau; Marie Besson; Jules Desmeules; Christine Cedraschi
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.